Immediate thrombocytopenia at time of alemtuzumab infusion for multiple sclerosis - Not always self-limiting, fully reversible or predictable

Mult Scler. 2018 Apr;24(4):552-553. doi: 10.1177/1352458517719151. Epub 2017 Jun 29.

Authors

Siew Mei Yap¹, Nuala McNicholas¹, Michael Hutchinson¹, Christopher McGuigan¹

Affiliation

¹ Department of Neurology, St. Vincent's University Hospital, Dublin, Ireland.

PMID: 28661220
DOI: 10.1177/1352458517719151

No abstract available

Publication types

Letter
Comment

MeSH terms

Alemtuzumab
Antibodies, Monoclonal, Humanized
Humans
Multiple Sclerosis*
Multiple Sclerosis, Relapsing-Remitting*
Thrombocytopenia*

Substances

Antibodies, Monoclonal, Humanized
Alemtuzumab